VIVUS, Inc. (NASDAQ:VVUS) announced that it will report financial results for the fourth quarter and year ended December 31, 2015 after the NASDAQ Market closes on Wednesday, March 9, 2016. The company will conduct a conference call and an audio webcast at 4:30 pm EST the same day.
VIVUS Inc. (NASDAQ:VVUS) belongs to Healthcare sector. Its weekly performance is -0.95%. On last trading day company shares ended up at $1.04.
Novavax Inc. (NASDAQ:NVAX) reported a net loss of $78.8 million, or $0.29 per share, for the fourth quarter of 2015, compared to a net loss of $31.5 million, or $0.13 per share, for the fourth quarter of 2014. For the twelve months ended December 31, 2015, the net loss was $156.9 million, or $0.60 per share, compared to a net loss of $82.9 million, or $0.37 per share, for the same period in 2014.
Novavax, Inc. (NASDAQ:NVAX) shares fell -7.43% in last trading session and ended the day at $4.36. NVAX Gross Margin is 71.20% and its return on assets is -28.40%. Novavax, Inc. (NASDAQ:NVAX) quarterly performance is -45.36%.
Rollins, Inc. (NYSE:ROL), a premier global consumer and commercial services company, announced that the Board of Directors approved a 25.0% increase in the Company’s quarterly cash dividend. The increased regular quarterly cash dividend of $0.10 per share will be payable March 10, 2016 to stockholders of record at the close of business February 10, 2016. This marks the fourteenth consecutive year the Board has increased its dividend a minimum of 12% or greater.
On 29 February, Rollins Inc. (NYSE:ROL) shares fell -0.83% and was closed at $27.53. ROL EPS growth in last 5 year was 11.80%. Rollins Inc. (NYSE:ROL) year to date (YTD) performance is 6.70%.
On 16 February, Bioanalytical Systems Inc. (NASDAQ:BASI) reported Service revenue for the first quarter of fiscal 2016 decreased 7.8% to $4,055,000 compared to $4,398,000 for the same period in fiscal 2015. Increased preclinical services revenue was more than offset by lower other laboratory services revenue, due to fewer bioequivalence studies, and a decline in Bioanalytical revenue, due to fewer samples received and analyzed and a mix favoring method development and validation projects in the first three months of fiscal 2016 versus the comparable period in fiscal 2015.
Bioanalytical Systems Inc. (NASDAQ:BASI) ended the last trading day at $1.21. Company weekly volatility is calculated as 10.39% and price to cash ratio as 24.50. Bioanalytical Systems Inc. (NASDAQ:BASI) showed a weekly performance of 9.01%.
Internet Initiative Japan Inc. (NASDAQ:IIJI) shares moved up 5.46% in last trading session and ended the day at $10.24. IIJI Gross Margin is 17.40% and its return on assets is 3.30%. Internet Initiative Japan Inc. (NASDAQ:IIJI) quarterly performance is 9.28%.